India's central drug authority, CDSCO, has directed State and Union Territory drug regulators to identify and take action against manufacturers and marketers of unapproved drug products containing Enclomiphene and its combinations. The regulator has reiterated that such products cannot be manufactured or marketed without the required regulatory approval, reinforcing compliance under India’s drug regulatory framework.
In India, lawyers and law firms are not permitted to solicit work and advertise themselves. By clicking on the “I agree” button, you hereby agree and acknowledge that:
The information contained on this website is for general informational purposes only. While Arogya Legal strives to keep the information up to date and accurate, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability, or availability of the information, products, services, or related graphics contained on the website.
The content on this website, including articles, videos, news updates, and other materials, is intended for informational purposes only and should not be construed as legal advice. No attorney-client relationship is created by accessing this website, reading its content, or contacting us through the website. For specific legal advice regarding your situation, please consult with a qualified legal professional.
Submitting a contact form, sending an email, or any other form of communication through this website does not establish a professional relationship between you and Arogya Legal. A professional engagement is only formed upon execution of a formal engagement letter or agreement.
Regulatory requirements and legal provisions are subject to change. While we make every effort to ensure that the regulatory information on our website is current, laws, rules, and regulations may be amended or updated by the relevant authorities. Users are advised to verify the latest regulatory requirements with the appropriate government authorities before making any business decisions.
This website may contain links to external websites that are not provided or maintained by Arogya Legal. We do not guarantee the accuracy, relevance, timeliness, or completeness of any information on these external websites and are not responsible for their content or privacy practices.
In no event shall Arogya Legal, its partners, employees, or affiliates be liable for any loss or damage, including without limitation, indirect or consequential loss or damage, arising out of or in connection with the use of this website or reliance on any information provided herein.
If you have any questions about this Disclaimer, please contact us at contact@arogyalegal.com .